• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » In Brief: A 16-Hour Ritalin

In Brief: A 16-Hour Ritalin

October 3, 2019
Chris Aiken, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Adhansia XR is a new extended-release methylphenidate. Its distinguishing feature is its 16-hour duration, which breaks the previous record of 12 hours set by Concerta, Cotempla, Aptensio, and Quillivant. In that respect it is similar to Mydayis, the 16-hour version of Adderall. Adhansia XR releases 20% of its methylphenidate through instant-release beads. The other 80% is distributed through controlled-release layers. The max dose (85 mg) is slightly higher than other methylphenidate products because the drug is distributed over a longer period of time.

In essence, Adhansia XR is equivalent to Ritalin LA dosed BID, or Concerta with an instant-release methylphenidate added on at the 12-hour mark. Those generic versions offer the same pharmacokinetics at one-third the cost, and allow patients to take less on days when 12 hours of coverage is enough.

Chris Aiken, MD.


General Psychiatry
KEYWORDS adhansia-xr adult-adhd ritalin
Aiken
Chris Aiken, MD

Six Tips From Prescribing Psychotropics

More from this author
www.thecarlatreport.com
Issue Date: October 3, 2019
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Mental Health Apps, TCPR, October 2019
Treating Sexual Dysfunction in Women
Using Mental Health Apps
FDA Approves a Hormonal Injection for Low Libido in Women
Anti-Inflammatories as Antidepressants?
Highlights From This Issue
In Brief: A 16-Hour Ritalin
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.